Interferon (IFN)-gamma, in common with a number of cytokines or growth
factors, strongly interacts with heparan sulphate (HS). It has been s
hown previously that one of the C-terminal basic clusters of amino aci
ds (a regulatory element of IFN-gamma activity) is involved in this in
teraction. The structural organization of the HS domain that binds to
human IFN-gamma has been investigated here. IFN-gamma-affinity chromat
ography of HS oligosaccharides released by either enzymic or chemical
cleavage showed that the binding site is not found in a domain that is
resistant to either heparinase or heparitinase or exclusively N-sulph
ated. or N-acetylated. This led us to take a 'footprinting' approach i
n which HS was depolymerized in the presence of IFN-gamma and the cyto
kine-protected sequences were separated from the digested fragments. U
sing this strategy we consistently isolated an IFN-gamma-protected dom
ain (IPD; approx. 10 kDa) which displayed the same affinity as full-le
ngth HS for the cytokine. Treatment of IPD with either heparinase or h
eparitinase strongly reduced its affinity, confirming that the high-af
finity binding site encompassed a mixture of HS structural domains. Pa
tterns of depolymerization with either enzymic or chemical agents were
consistent with IPD being composed of an extended internal domain (ap
prox. 7kDa) which is predominantly N-acetylated and GlcA-rich, Banked
by small N-sulphated oligosaccharides (mainly hexa- to octasaccharides
). This is the first description of an HS protein-binding sequence wit
h this type of molecular organization. Furthermore, using a cross-link
ing strategy, we demonstrated that one HS molecule bound to an IFN-gam
ma dimer. Together these results lead us to propose a novel model for
the interaction of HS with a protein, in which two sulphated terminal
sequences of the binding domain interact directly with the two IFN-gam
ma C-termini and bridge the two cytokine monomers through an internal
N-acetyl-rich sequence.